psilocybin mushroom

psilocybin mushroom, any of several species of hallucinogenic fungi found across a number of genera, especially Psilocybe mexicana and P. cubensis. Often called “magic mushrooms,” psilocybin mushrooms produce two primary psychoactive compounds, psilocybin and psilocin, which are responsible for their mind-altering effects. Many psilocybin mushrooms have a long history of traditional use and are popular as recreational drugs.

There are more than 100 psilocybin mushroom species worldwide, the majority of which are members of the genus Psilocybe. Other genera with psilocybin-containing fungi include Agrocybe, Copelandia, Galerina, Gerronema, Gymnopilus, Hypholoma, Inocybe, Panaeolus, Pholiotina, and Pluteus. While the fungi can be found on every continent except Antarctica, most species are found in tropical and subtropical forests and are especially common in Mexico. In general, psilocybin mushrooms are gilled and produce dark spores; they may closely resemble poisonous species.

Uses

Psilocybin mushrooms have been used for hundreds or thousands of years by Indigenous groups around the world. Often considered sacred, the mushrooms have been important for healing, divination, and spiritual rites in a number of cultures. The Aztecs referred to these mushrooms as “the flesh of the gods.” Some Central and South American curanderos (Spanish: “healers” or “shamans”) regard the fungi as teachers who can inspire, instruct, and even discipline their users.

Psilocybin mushrooms were researched from the 1950s to the 1970s by a few prominent academics, including Harvard University’s Timothy Leary and Richard Alpert. The men publicized the fungi’s consciousness-expanding properties, which are somewhat similar to synthetic drugs such as LSD. Widespread recreational use of these mushrooms, however, prompted state and federal governments to strictly control them in many places. 

In the 21st century, psilocybin mushrooms have been tested as a treatment for chronic mental disorders such as anxiety, depression, addiction, and post-traumatic stress disorder (PTSD). In the United States, the Department of Veterans Affairs has been testing psilocybin and psilocin in an effort to reduce veterans’ mental health problems and suicide rates. While scientists still seek to understand the ways in which these mushrooms alter brain functions, some results suggest that their active components may have the ability to break old neural connections and to create new ones, potentially reducing negative or obsessive thinking and allowing patients to develop more positive behaviours.

Mechanism of action and effects

Psilocybin and psilocin enter the brain through the same receptors as serotonin, a hormone that regulates sleep, sexual desire, and emotional states such as happiness and satisfaction. The mind-altering effects usually begin about 20 to 30 minutes after ingestion and can continue for as long as six to eight hours. The experience may seem to last much longer because the user’s perception of time can be radically altered. Typical side effects from the compounds include nausea, vomiting, muscle weakness, drowsiness, and euphoria. 

The effects of psilocybin and psilocin are highly subjective, depending on the type of mushroom, how it is prepared, the dose used in a session, and what is known as the “set” and the “setting.” The set involves the psychological state of the user. The setting refers to the environment of the session, which includes the physical surroundings as well as the skill of the person, if any, leading the group or session. Users experience sensory, emotional, and neural changes during a session. 

As the compounds take effect, a range of distorted and heightened sensory impressions begins to occur. Users may see vivid colours or auras around objects and people, witness objects morphing into other forms, and perceive sounds as more complex and profound. They may even experience synesthesia, a “scrambling” of the senses in which a person may see sounds, hear colours, and taste forms. These sensory effects usually peak about three to four hours after ingestion and then begin to taper off.

Psilocybin and psilocin usually intensify emotional responses. A person taking a moderate dose with friends in a familiar environment is more likely to feel a sense of happiness, euphoria, and oneness with all life. In contrast, someone taking a large dose or someone who is anxious and lacks trust in the setting is more likely to have a disturbing experience. This can include panic, paranoia, and even psychotic episodes. In both cases, users cannot distinguish between fantasy and reality—everything appears vividly real, whether blissful or frightening.